Breast Cancer Screening Market Analysis: Key Insights and Future Outlook
According to Renub Research, the global breast cancer screening market is expected to reach US$ 2.13 Billion by 2028, driven by growing awareness, technological advancements, and government initiatives. Early detection is crucial in treating breast cancer effectively, increasing survival rates, and reducing the need for aggressive treatment. As a result, the breast cancer screening market is experiencing a robust CAGR of 4.45% from 2022 to 2028.
Rising Breast Cancer Incidences and Demand for Screening
Breast cancer is the most prevalent cancer globally, with over 2.3 million new cases each year, according to the World Health Organization (WHO). This increase, combined with campaigns promoting early detection and better access to healthcare services, has led to higher demand for screening technologies like mammography, ultrasound, and MRI. Governments and healthcare organizations worldwide are implementing programs to make these services more accessible, particularly to underserved populations.
Technological Advancements in Breast Cancer Screening
Advancements in screening technology have revolutionized the market. Digital mammography, breast ultrasound, and MRI have improved accuracy and reduced the invasiveness of screening methods. For example, in March 2022, LifeCell launched the Breast Screen Panel, a comprehensive genetic screening test that assesses a woman’s risk of breast cancer. Such innovations are expected to drive market growth as they provide patients with more precise diagnostic tools.
Related Reports
Market Growth Across Key Regions
- United States: With high breast cancer incidence rates, health insurance plans and government policies have made mammography more accessible. The National Breast Cancer Foundation‘s goal of “zero fatalities from breast cancer” by 2030 is backed by USD 12.4 million in research funding, further pushing the U.S. market forward.
- India and China: In emerging markets like India and China, rising disposable incomes and government initiatives such as the National Programme for Prevention and Control of Cancer (India) and National Breast Cancer Screening Program (China) have enhanced access to screening services, particularly in rural areas.
- Brazil: The private healthcare sector in Brazil is adopting advanced screening technologies like MRI, supported by growing awareness among women about the importance of early detection through screening.
Ultrasound and MRI Screening on the Rise
Ultrasound screening has gained popularity, especially for younger women or those with dense breast tissue. China is leading the adoption of ultrasound technology as the primary screening method due to government-backed initiatives. In the United States, advanced 3D and 4D ultrasound technologies are improving the accuracy of screenings, complementing mammography in detecting breast cancer more effectively.
Key Players Shaping the Market
The breast cancer screening market is highly competitive, with major players like AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline leading the way in innovations and market share. In June 2022, Walmart partnered with Biomerica, Inc. to sell the Aware Breast Self-Exam device, further democratizing access to screening tools through retail platforms.
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com
Sandy D